Synthetic lethality - EZH2 inhibitor tazemetostat in INI1-negative tumors

Date

05 Mar 2018

Session

Novel epigenetic targets

Presenters

Antoine Italiano

Authors

A. Italiano

Author affiliations

  • Early Phase Trials Unit, Institute Bergonié, 33076 - Bordeaux/FR
More

Resources

Resources from the same session

Introduction

Presenter: Susan Bates

Session: Novel epigenetic targets

Resources:

Presentation

Webcast

BET domain inhibitors

Presenter: Irene Brana Garcia

Session: Novel epigenetic targets

Resources:

Presentation

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings